Fushimi Shuto, Akimoto Taisuke, Otomo Yuta, Iida Yu, Miyake Shigeta, Ohtake Makoto, Hori Satoshi, Suenaga Jun, Nakai Yasunobu, Yamamoto Tetsuya
Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Neurosurgery, Yokohama City University Medical Center, Yokohama, JPN.
Cureus. 2024 Dec 15;16(12):e75759. doi: 10.7759/cureus.75759. eCollection 2024 Dec.
Background and purpose The risk of rupture increases with advancing age. However, the risk-benefit of coil embolization for elderly patients with unruptured aneurysms is controversial. This study aimed to identify factors associated with treatment primary outcomes, including risk factors for complications and aneurysm recurrence requiring re-treatment in the endovascular treatment of unruptured aneurysms in elderly patients. In addition, deterioration of the modified Rankin Scale (mRS) was examined as a secondary outcome. Materials and methods This retrospective three-center study examined 112 cases of coiled unruptured aneurysms in patients aged ≥ 60 years using endovascular registry data from January 2018 to March 2022. We examined patient background, aneurysm characteristics, adjuvant technique, symptomatic complications, and mRS scores. Results The average age of the patients was 72.5±6.9 years, and 83 cases (74.1%) were female. During the postoperative follow-up period (six to 36 months), no deaths occurred, one case of postoperative rupture was observed, and nine patients (5.4%) were re-treated. Notably, age, underlying disease, aneurysm location, and re-treatment were not associated with complications. In the multivariate logistic analysis for re-treatment, symptomatic complications [odds ratio (OR) 11.01; 95% confidence interval (CI), 3.68-52.5; p < 0.001] and re-treatment (OR 3.25; 95% CI, 1.04-10.7; p = 0.039) were independently associated with mRS score deterioration. The risk factors for re-treatment were maximum aneurysm diameter and aneurysm neck diameter; aneurysms with neck diameters and maximum diameters > 5.0 mm and > 9.0 mm, respectively, had a higher rate of need for re-treatment (33%) and mRS score deterioration (33%) due to re-enlargement of the aneurysm. Conclusion In this study, complications did not increase with age in those aged 60 and older. However, prioritizing the avoidance of complications in elderly patients is important. Elderly patients with aneurysms larger than 9 mm have a poor prognosis and require additional attention for re-treatment.
背景与目的 破裂风险随年龄增长而增加。然而,老年未破裂动脉瘤患者进行弹簧圈栓塞治疗的风险效益存在争议。本研究旨在确定与治疗主要结局相关的因素,包括老年患者未破裂动脉瘤血管内治疗中并发症的危险因素以及需要再次治疗的动脉瘤复发危险因素。此外,将改良Rankin量表(mRS)恶化作为次要结局进行研究。材料与方法 这项回顾性三中心研究使用2018年1月至2022年3月的血管内登记数据,对112例年龄≥60岁的未破裂动脉瘤弹簧圈栓塞病例进行了研究。我们检查了患者背景、动脉瘤特征、辅助技术、症状性并发症和mRS评分。结果 患者的平均年龄为72.5±6.9岁,83例(74.1%)为女性。术后随访期间(6至36个月),无死亡病例,观察到1例术后破裂,9例患者(5.4%)接受了再次治疗。值得注意的是,年龄、基础疾病、动脉瘤位置和再次治疗与并发症无关。在再次治疗的多因素逻辑分析中,症状性并发症[比值比(OR)11.01;95%置信区间(CI),3.68 - 52.5;p < 0.001]和再次治疗(OR 3.25;95% CI,1.04 - 10.7;p = 0.039)与mRS评分恶化独立相关。再次治疗的危险因素是动脉瘤最大直径和瘤颈直径;瘤颈直径和最大直径分别>5.0 mm和>9.0 mm的动脉瘤,因动脉瘤再扩大而需要再次治疗的比例(33%)和mRS评分恶化的比例(33%)更高。结论 在本研究中,60岁及以上患者的并发症不会随年龄增加。然而,优先避免老年患者出现并发症很重要。动脉瘤大于9 mm的老年患者预后较差,再次治疗需要格外关注。